Search results for "Highlights"
Patients with type 2 diabetes at higher risk for AKI, even without pre-existing kidney disease
The authors of the retrospective study called for additional research on the pathogenesis of acute kidney injury (AKI) and the associated risk factors, such as medications, in diabetic patients.
https://diabetes.acponline.org/archives/2020/10/09/3.htm
9 Oct 2020
Recent-onset diabetes, weight loss associated with increased pancreatic cancer risk
Unintentional weight loss and weight loss in those with a body mass index already in the normal range were particularly associated with risk of pancreatic cancer among patients with recent-onset diabetes, a study found.
https://diabetes.acponline.org/archives/2020/09/11/2.htm
11 Sep 2020
Hospitalizations for diabetes complications fell, were replaced by other causes
An analysis of excess hospitalizations among people with diabetes in England from 2003 to 2018 found that diabetes caused fewer of their hospital stays, with respiratory disease and cancer becoming more predominant diagnoses.
https://diabetes.acponline.org/archives/2021/12/10/1.htm
10 Dec 2021
AHA scientific statement reviews research on drugs for diabetes and chronic kidney disease
The advent of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists could reduce cardiovascular adverse events and progression to end-stage kidney disease, the American Heart Association (AHA) scientific statement noted.
https://diabetes.acponline.org/archives/2020/10/09/2.htm
9 Oct 2020
Consensus report issued on management of type 1 diabetes in adults
The report from the American Diabetes Association and European Association for the Study of Diabetes offers guidance on diagnosis, management, and treatment, among other topics. Their recommendations are evidence-based where possible but represent the consensus opinion of the authors.
https://diabetes.acponline.org/archives/2021/10/08/1.htm
8 Oct 2021
Spotlight on amputations
Recent studies analyzed data on lower-extremity amputations among patients with diabetes, including recent trends in this complication and its associated mortality, effects of the pandemic, and relationships with diabetes drugs.
https://diabetes.acponline.org/archives/2020/08/14/5.htm
14 Aug 2020
Patient-led titration of basal insulin appears effective in type 2 diabetes
A meta-analysis of six studies found that patient-led titration was associated with lower HbA1c and fasting plasma glucose levels than physician-led titration, although hypoglycemia risk and body weight were slightly higher.
https://diabetes.acponline.org/archives/2020/08/14/3.htm
14 Aug 2020
Adverse events associated with SGLT-2 inhibitors do not appear dose-dependent
In a systematic review and meta-analysis, no difference was seen between high- and low-dose sodium-glucose cotransporter-2 (SGLT-2) inhibitors in overall safety or specific safety outcomes, other than a mild increased risk for adverse events with higher doses of canagliflozin.
https://diabetes.acponline.org/archives/2020/09/11/3.htm
11 Sep 2020
Pain in diabetes-related polyneuropathy associated with adverse events, death
Patients with type 2 diabetes who had no diabetes-related polyneuropathy, diabetes-related polyneuropathy with pain, and diabetes-related polyneuropathy without pain were compared in an industry-funded retrospective study.
https://diabetes.acponline.org/archives/2020/07/10/3.htm
10 Jul 2020
Consensus report aims to define remission of diabetes
An international expert group convened by the American Diabetes Association proposed that the criterion for diabetes remission be an HbA1c level below 6.5%, measured at least three months after glucose-lowering drugs are stopped.
https://diabetes.acponline.org/archives/2021/09/10/1.htm
10 Sep 2021